Effect of nordy on the function of endothelial progenitor cells from human umbilical cord blood induced by vascular endothelial growth factor.
- Author:
Hua-Rong ZHANG
1
;
Cheng-Ping XU
;
Fei-Lan CHEN
;
Xiu-Wu BIAN
Author Information
1. Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents;
pharmacology;
Cell Movement;
drug effects;
Cell Proliferation;
drug effects;
Cells, Cultured;
Endothelial Cells;
cytology;
Fetal Blood;
cytology;
Humans;
Masoprocol;
analogs & derivatives;
pharmacology;
Neovascularization, Physiologic;
drug effects;
Stem Cells;
cytology;
Vascular Endothelial Growth Factor A;
antagonists & inhibitors
- From:
Acta Pharmaceutica Sinica
2008;43(2):133-137
- CountryChina
- Language:Chinese
-
Abstract:
This study is to investigate whether the synthesized chiral compound Nordy has influence on the function of endothelial progenitor cells (EPCs) from human umbilical cord blood induced by vascular endothelial growth factor (VEGF). EPCs were isolated from human umbilical cord blood by density gradient centrifugation. After cultured for 7 -10 days, EPCs were prepared for detecting effect of Nordy on proliferation, migration and tubule-forming activity in Matrigel induced by VEGF. Incubation of EPCs with 100 micromol L(-1) Nordy for 24 h initially inhibited the proliferative capacity of EPCs induced by VEGF (P <0.05). Moreover, 25 -50 micromol L(-1) Nordy also exhibited inhibitory effect at 48 -72 h. In addition, 25 - 100 micromol L(-1) Nordy impaired EPCs migratory and tubule-forming capacity in vitro (P < 0.05). Nordy could inhibit in EPCs the functions of proliferation, migration and tubulogenesis induced by VEGF in vitro, which might be a possible mechanism of its anti-EPCs effects.
